Europe Spatial Genomics & Transcriptomics Market Size & Outlook
Europe spatial genomics & transcriptomics market, 2018-2030 (US$M)
Related Markets
Europe spatial genomics & transcriptomics market highlights
- The Europe spatial genomics & transcriptomics market generated a revenue of USD 90.1 million in 2023.
- The market is expected to grow at a CAGR of 11.1% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 90.1 million |
| Market revenue in 2030 | USD 188.4 million |
| Growth rate | 11.1% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.1% of the global spatial genomics & transcriptomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 139.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics & Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe spatial genomics & transcriptomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to spatial genomics & transcriptomics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.61% in 2023. Horizon Databook has segmented the Europe spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
The European spatial genomics and transcriptomics market is expected to witness significant growth due to advancements in the fields of genomics, sequencing, and biochemical technologies. Presence of genome sequencing firms such as 24 Genetics and Dante Labs has ensured easy accessibility of genome sequencing services in the region.
Moreover, presence of rapidly growing genomic companies such as Oxford Nanopore, CureVac, and Immunocore can increase Europe’s potential in the global market and penetration of m-RNA-based gene expression techniques in the region.
In 2016, France announced the launch of “France Medecine Genomique 2025” program with an aim to open 12 sequencing centers across the country to carry out 235,000 whole genome sequencing annually.
Reasons to subscribe to Europe spatial genomics & transcriptomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe spatial genomics & transcriptomics market databook
-
Our clientele includes a mix of spatial genomics & transcriptomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe spatial genomics & transcriptomics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe spatial genomics & transcriptomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe spatial genomics & transcriptomics market size, by country, 2018-2030 (US$M)
Europe Spatial Genomics & Transcriptomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
